Successful Outcomes with Oral Fluoroquinolones Combined with Rifampicin in the Treatment of Mycobacterium ulcerans: An Observational Cohort Study

BACKGROUND: The World Health Organization currently recommends combined streptomycin and rifampicin antibiotic treatment as first-line therapy for Mycobacterium ulcerans infections. Alternatives are needed when these are not tolerated or accepted by patients, contraindicated, or neither accessible n...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: O'Brien, Daniel P., McDonald, Anthony, Callan, Peter, Robson, Mike, Friedman, N. Deborah, Hughes, Andrew, Holten, Ian, Walton, Aaron, Athan, Eugene
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2012
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3260310/
https://ncbi.nlm.nih.gov/pubmed/22272368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0001473
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars